Incannex Healthcare granted extension to meet Nasdaq bid price rule
PositiveFinancial Markets

Incannex Healthcare has received an extension from Nasdaq to comply with its bid price rule, allowing the company more time to meet the necessary requirements. This extension is significant as it provides Incannex with an opportunity to stabilize its stock price and continue its operations without the immediate pressure of delisting. Such developments are crucial for investors and stakeholders, as they indicate the company's potential for recovery and growth in the competitive healthcare market.
— Curated by the World Pulse Now AI Editorial System